[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1107298T1 - Υδατοδιαλυτα κοκκια μελοξικαμης - Google Patents

Υδατοδιαλυτα κοκκια μελοξικαμης

Info

Publication number
CY1107298T1
CY1107298T1 CY20081100265T CY081100265T CY1107298T1 CY 1107298 T1 CY1107298 T1 CY 1107298T1 CY 20081100265 T CY20081100265 T CY 20081100265T CY 081100265 T CY081100265 T CY 081100265T CY 1107298 T1 CY1107298 T1 CY 1107298T1
Authority
CY
Cyprus
Prior art keywords
meloxicam
water soluble
soluble granules
sweetener
relates
Prior art date
Application number
CY20081100265T
Other languages
English (en)
Inventor
Martin Andreas Folger
Stefan Henke
Jens Schmalz
Diana Christine Keilhofer
Hans-Jürgen Kroff
Nina Herz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY1107298T1 publication Critical patent/CY1107298T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση αφορά κοκκία μελοξικάμης, που είναι ταχέως διαλυτά σε νερό και περιέχουν μελοξικάμη, ένα μέσο σχηματισμού αλάτων που σχηματίζει το άλας μεγλουμίνης, νατρίου, καλίου ή αμμωνίου της μελοξικάμης, ένα συνδετικό μέσο, ένα σάκχαρο ή μια γλυκαντική ουσία, ένα φορέα, ενδεχομένως μια αρωματική ουσία και ενδεχομένως περαιτέρω βοηθητικές ουσίες. Η εφεύρεση αφορά επίσης μια μέθοδο παρασκευής αυτών καθώς και τη χρησιμοποίηση τους για την αγωγή αναπνευστικών ή φλεγμονωδών ασθενειών σε θηλαστικά.
CY20081100265T 2002-10-25 2008-03-07 Υδατοδιαλυτα κοκκια μελοξικαμης CY1107298T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10250081A DE10250081A1 (de) 2002-10-25 2002-10-25 Wasserlösliche Meloxicam Granulate
EP03809321A EP1558262B1 (de) 2002-10-25 2003-10-24 Wasserlösliche meloxicam granulate

Publications (1)

Publication Number Publication Date
CY1107298T1 true CY1107298T1 (el) 2012-11-21

Family

ID=32103087

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100265T CY1107298T1 (el) 2002-10-25 2008-03-07 Υδατοδιαλυτα κοκκια μελοξικαμης

Country Status (28)

Country Link
US (1) US20130005714A1 (el)
EP (1) EP1558262B1 (el)
JP (2) JP4856377B2 (el)
KR (1) KR101152689B1 (el)
CN (1) CN1708307B (el)
AR (1) AR041717A1 (el)
AT (1) ATE381337T1 (el)
AU (1) AU2003276170B2 (el)
BR (1) BR0315639A (el)
CA (1) CA2503396C (el)
CO (1) CO5570680A2 (el)
CY (1) CY1107298T1 (el)
DE (2) DE10250081A1 (el)
DK (1) DK1558262T3 (el)
ES (1) ES2298619T3 (el)
HK (1) HK1084878A1 (el)
HR (1) HRP20050366B1 (el)
MX (1) MXPA05004211A (el)
MY (1) MY136901A (el)
PE (1) PE20040495A1 (el)
PL (1) PL212425B1 (el)
PT (1) PT1558262E (el)
RU (1) RU2333744C2 (el)
TW (1) TWI336622B (el)
UA (1) UA81785C2 (el)
UY (1) UY28039A1 (el)
WO (1) WO2004037264A1 (el)
ZA (1) ZA200502702B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CN1680427B (zh) * 2005-02-01 2010-08-11 杨喜鸿 易于水溶解的匹多莫德复盐及其制备方法
EP1793801A1 (en) * 2005-07-15 2007-06-13 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
CN101277701A (zh) * 2005-09-30 2008-10-01 贝林格尔·英格海姆维特梅迪卡有限公司 含有美洛昔康的药物制剂
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
US7772255B2 (en) * 2005-12-13 2010-08-10 Supratek Pharma, Inc. Method of treating tumors with azaxanthones
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
TR200809200A1 (tr) * 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
IN2012DN03157A (el) 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2465892C1 (ru) * 2011-09-21 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" Способ получения высокодисперсного мелоксикама
CN103705479B (zh) * 2012-09-29 2017-11-28 瑞普（天津）生物药业有限公司 一种宠物用美洛昔康缓释片及其制备方法
RU2559000C1 (ru) * 2014-02-25 2015-08-10 Вячеслав Михайлович Спиридонов Кормовая добавка бфк
US9526734B2 (en) * 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
WO2016086114A1 (en) * 2014-11-25 2016-06-02 Artdem, Llc Sports drink formulation
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
CN109983013A (zh) * 2016-11-18 2019-07-05 帕西拉制药有限公司 美洛昔康锌复合物微粒多囊脂质体制剂及其制备方法
JP2019163249A (ja) * 2018-03-16 2019-09-26 フジタ製薬株式会社 メロキシカム水性溶液

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102416A (en) * 1976-02-19 1977-08-27 Okawara Mfg Granule making method of herb medicine and like
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒，その製造法および錠剤
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0912426A (ja) * 1995-06-29 1997-01-14 Asahi Chem Ind Co Ltd 吸湿性物質組成物
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
AU2001262731A1 (en) * 2000-06-20 2002-01-02 Fujisawa Pharmaceutical Co. Ltd. Tetracyclic compounds-containing pharmaceutical preparations
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate

Also Published As

Publication number Publication date
HRP20050366A2 (en) 2006-06-30
CN1708307A (zh) 2005-12-14
UY28039A1 (es) 2004-05-31
RU2005115955A (ru) 2006-02-10
CA2503396A1 (en) 2004-05-06
PE20040495A1 (es) 2004-09-17
WO2004037264A1 (de) 2004-05-06
AR041717A1 (es) 2005-05-26
RU2333744C2 (ru) 2008-09-20
PT1558262E (pt) 2008-01-18
KR101152689B1 (ko) 2012-06-15
BR0315639A (pt) 2005-08-30
US20130005714A1 (en) 2013-01-03
UA81785C2 (uk) 2008-02-11
JP4856377B2 (ja) 2012-01-18
HRP20050366B1 (hr) 2013-12-06
CN1708307B (zh) 2011-12-07
ZA200502702B (en) 2008-01-30
KR20050070079A (ko) 2005-07-05
CA2503396C (en) 2011-12-13
HK1084878A1 (en) 2006-08-11
TW200501961A (en) 2005-01-16
DE50308863D1 (de) 2008-01-31
DE10250081A1 (de) 2004-05-13
MY136901A (en) 2008-11-28
EP1558262A1 (de) 2005-08-03
DK1558262T3 (da) 2008-01-28
CO5570680A2 (es) 2005-10-31
AU2003276170A1 (en) 2004-05-13
ES2298619T3 (es) 2008-05-16
AU2003276170B2 (en) 2009-07-16
PL212425B1 (pl) 2012-09-28
JP5579132B2 (ja) 2014-08-27
TWI336622B (en) 2011-02-01
PL375479A1 (en) 2005-11-28
JP2006505574A (ja) 2006-02-16
MXPA05004211A (es) 2005-06-08
JP2011213726A (ja) 2011-10-27
EP1558262B1 (de) 2007-12-19
ATE381337T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
CY1107298T1 (el) Υδατοδιαλυτα κοκκια μελοξικαμης
CY1107084T1 (el) Παραγωγα πυρρολοπυριδαζινης
CY1123050T1 (el) Φαρμακα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
CY1106589T1 (el) (s)-2-ν-προπυλαμινο-5-υδροξυτετραλινη ως d3-αγωνιστικο θεραπευτικο μεσο
CY1106634T1 (el) Θεραπευτικα παραγωγα της πιπεραζινης
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
ATE408601T1 (de) Fredericamycin-derivate
CY1118020T1 (el) Τροποποιημενα φθοριομενα αναλογα νουκλεοζιδιων
CY1119481T1 (el) Εισπνευσιμη επινεφρινη
CY1113190T1 (el) Μεθοδος αγωγης της αιμολυτικης νοσου
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
CY1108533T1 (el) Ανθελμινθικες στοματικες ομοιογενεις κτηνιατρικες παστες
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
CY1106003T1 (el) Παραγωγα του ν-βενζοϋλοουρεϊδο-κινναμωμικου οξεος, μεθοδος για την παρασκευη τους και η χρηση τους
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
DE60108489D1 (de) Kombinationstherapien mit gefässschädigender aktivität
CY1112366T1 (el) Ενωσεις βενζιμιδαζολης- καρβοξαμιδης ως αγωνιστες του 5-ητ4 υποδοχεα
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
CY1106026T1 (el) Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας
CY1111734T1 (el) Χρηση παραγωγου αμιδιου του παραγοντα a3 του ge 2270 για την αγωγη της ακμης
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
EA200601438A1 (ru) Аморфные формы мононатриевой соли ризедроновой кислоты